About Us

Established in 1999, The Australia New Zealand Melanoma Trials Group recognised the need to centrally promote and support melanoma trials for investigators and consumers.

ANZMTG's first project was to design and support a randomised Phase III trial in melanoma comparing adjuvant radiotherapy to observation in patients with resected nodal disease. Since then ANZMTG has been developing and conducting new clinical trial protocols and research projects.

ANZMTG Membership is open to consumers, researchers, health professionals and industry representatives from Australia and New Zealand. Membership is also available to international researchers and health professionals.

Member Overview (downloadable PDF)